SCHEMBL903892

SCHEMBL903892

C=S(C)(=O)N1CCN(Cc2ccc(OC3CC4CN(C(=O)OC(C)(C)C)CC4C3)c(F)c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GPR119 Q8TDV5 5/20 0.48
GRIN1 Q05586 4/20 0.40
GRIN2B Q13224 4/20 0.40
F13A1 P00488 1/20 0.39
TGM2 P21980 1/20 0.39
TGM1 P22735 1/20 0.39
IDO1 P14902 1/20 0.38
TDO2 P48775 1/20 0.38
IDO2 Q6ZQW0 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALDH1A1 P00352 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NR1H2 P55055 1/20 0.38
S1PR5 Q9H228 1/20 0.37
SCN9A Q15858 2/20 0.37
POLB P06746 1/20 0.37
JAK2 O60674 1/20 0.36
JAK1 P23458 1/20 0.36
PDE4B Q07343 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL903894 0.94 GPR119 (0.49) GPR119GRIN1GRIN2BIDO1TDO2
SCHEMBL903888 0.83 ALDH1A1 (0.44) GPR119IDO1TDO2IDO2KDM4E
SCHEMBL903880 0.83 KDM4E (0.42) GPR119KDM4EALDH1A1
SCHEMBL904003 0.83 ALDH1A1 (0.44) GPR119IDO1TDO2IDO2KDM4E
SCHEMBL23091766 0.76 GPR119 (0.48) GPR119GRIN1GRIN2BNR1H2PDE4B
SCHEMBL30013316 0.76 GPR119 (0.48) GPR119GRIN1GRIN2BNR1H2PDE4B
SCHEMBL27151214 0.75 GPR119 (0.47) GPR119GRIN1GRIN2BNR1H2PDE4B
SCHEMBL27151216 0.75 GPR119 (0.47) GPR119GRIN1GRIN2BNR1H2PDE4B
SCHEMBL10190043 0.71 UTS2R (0.44) IDO1TDO2IDO2SMN1; SMN2PDE4B
SCHEMBL322856 0.71 PDE4B (0.45) KDM4ESMN1; SMN2PDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012041158-A1 TRICYCLIC COMPOUND, PREPARATION METHOD AND PHARMACEUTICAL USE THEREOF 上海恒瑞医药有限公司 (CN) 2012-04-05 WO disclosed